期刊文献+

左卡尼汀在维持性血液透析患者中的临床应用 被引量:1

Clinical application of L-carnitine on maintence hemodialysis patients
下载PDF
导出
摘要 目的观察长期维持性血液透析患者(MHD)静脉补充左卡尼汀的临床疗效及不良反应。方法选择42例病情稳定1年以上的长期维持性血液透析患者,随机分为两组,治疗组于每次透析结束时静脉注射左卡尼汀1g,对照组静脉注射等量的生理盐水,共应用12周。结果静脉补充左卡尼汀组患者症状明显改善,血红蛋白、红细胞压积明显升高,血浆白蛋白及前清蛋白、转铁蛋白均有升高。药物不良反应轻微。结论左卡尼汀能有效改善维持性血液透析患者肉碱缺乏导致的临床症状。 Objective To evaluate effects and safety of L-camitine supplementation on maintenance hemodialysis patients (MHD) caused by carnitine deficiencies. Methods The experiment include forty-two MHD patients, all of them had undergone hemodialysis for at least one year before the experiment. They were randomly divided into two groups. For the therapy group, L-camitine 1 g intravenously infuse was given after every dialysissession. The observed course was 3 months. For the control group, intravenous injection normal saline was given. Results For the therapy group,improve clinical symptom significantly. Hb, Hct, serum albumin, prealbumin, transferrin were all raise. Adverse drug reactions were negligible. Conclusion L-carnitine can effectively improve clinical symptoms of maintence hemodialysis patients caused by earnitine deficiency.
作者 何洪斌 薛琳
出处 《四川医学》 CAS 2012年第8期1396-1398,共3页 Sichuan Medical Journal
关键词 血液透析 肉碱 左卡尼汀 hemodialysis carnitine L-carnitine
  • 相关文献

参考文献5

二级参考文献5

  • 1梅长林,中华肾脏病杂志,1998年,12卷
  • 2Chan M K,Nephron,1982年,30卷,240页
  • 3Evans A. Dialysis-related carnitine disorder and levocarnitine pharmacology[J]. Am J Kidney Dis, 2003,41 (4 suppl 4):S13 - S26.
  • 4Evans AM, Faull R, Fornasini G, et al. Pharmacokinetics of Lcarnitine in patients with end-stage renal disease undergoing longterm hemodialysis[J]. Clin Pharmacol Ther, 2000,68:238 - 249.
  • 5梅长林,徐洪实,顾书华,陈蕾,宋吉.血液透析患者游离肉碱测定及临床意义[J].中华肾脏病杂志,1998,14(6):383-383. 被引量:16

共引文献102

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部